Multidisciplinary treatment of opioid use disorder in primary care using the collaborative care model

被引:27
作者
Brackett, Charles D. [1 ,2 ,3 ]
Duncan, Matthew [3 ,4 ]
Wagner, Joanne Fadale [4 ]
Fineberg, Laura [2 ]
Kraft, Sally [2 ,3 ]
机构
[1] Dartmouth Hitchcock, Sect Gen Internal Med, Lebanon, NH USA
[2] Dartmouth Hitchcock, Populat Hlth, Lebanon, NH USA
[3] Dartmouth Coll, Geisel Sch Med Dartmouth, Hanover, NH 03755 USA
[4] Dartmouth Hitchcock, Dept Psychiat, Lebanon, NH USA
关键词
Buprenorphine; collaborative care model; opioid use disorder; medications for addiction treatment (MAT); behavioral health integration; BUPRENORPHINE; DEPRESSION; PHYSICIANS;
D O I
10.1080/08897077.2021.1932698
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Treatment of opioid use disorder (OUD) is highly effective, but access is limited and care is often fragmented. Treatment in primary care can improve access to treatment and address psychiatric and physical co-morbidities in a holistic, efficient, and non-stigmatizing way. The Collaborative Care Model (CCM) of behavioral health integration into primary care has been widely disseminated and shown to improve outcomes and lower costs when studied for depression, but its use in treating substance use disorders has not been well documented. Methods: We used a mixed-methods approach to examine the impact of implementing multidisciplinary treatment of OUD in our health system's five primary care clinics using the framework of the CCM, with care shared between the primary care clinician (PCP), behavioral health clinician, and medical assistant. The implementation included staff education, creation of electronic health record tools, and implementation support, and was evaluated using data from the electronic health record, the medical staff office, and a clinician survey. Results: Over the last 2 years of implementation, the number of waivered providers increased from 11 to 35, providers prescribing for 5 or more patients increased from 2 to 18, and patients initiated on buprenorphine increased from 4/month to 18/month. 180-day treatment retention was 53%, and 81% of patients had consistently negative urine drug testing. Psychiatric and medical comorbidities were common, 70 and 44%, respectively. Although PCPs who prescribed buprenorphine found working in this model enjoyable and effective, the majority of non-waivered PCPs remained reluctant to participate. Conclusions: In our experience, treatment of OUD in primary care utilizing the CCM effectively addresses OUD and commonly comorbid anxiety and depression, and leads to an expansion of treatment. Successful implementation of OUD treatment requires addressing negative attitudes and perceptions.
引用
收藏
页码:240 / 244
页数:5
相关论文
共 24 条
[1]   Collaborative care for depression and anxiety problems [J].
Archer, Janine ;
Bower, Peter ;
Gilbody, Simon ;
Lovell, Karina ;
Richards, David ;
Gask, Linda ;
Dickens, Chris ;
Coventry, Peter .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (10)
[2]  
Bloedorn, 2014, BRIEF ADDICTION MONI
[3]  
Boston Medical Center, 2016, POLICY PROCEDURE MAN
[4]   The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review [J].
Carroll, Kathleen M. ;
Weiss, Roger D. .
AMERICAN JOURNAL OF PSYCHIATRY, 2017, 174 (08) :738-747
[5]  
Department of Vermont Health Access managed care entity, 2015, VERM BUPR CLIN PRACT
[6]   Identification and Management of Opioid Use Disorder in Primary Care: an Update [J].
Donroe, Joseph H. ;
Bhatraju, Elenore P. ;
Tsui, Judith I. ;
Edelman, E. Jennifer .
CURRENT PSYCHIATRY REPORTS, 2020, 22 (05)
[7]   Narrowing the treatment gap in managing opioid use disorder [J].
Donroe, Joseph H. ;
Tetrault, Jeanette M. .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2018, 190 (09) :E236-E237
[8]   A Randomized Trial of Cognitive Behavioral Therapy in Primary Care-based Buprenorphine [J].
Fiellin, David A. ;
Barry, Declan T. ;
Sullivan, Lynn E. ;
Cutter, Christopher J. ;
Moore, Brent A. ;
O'Connor, Patrick G. ;
Schottenfeld, Richard S. .
AMERICAN JOURNAL OF MEDICINE, 2013, 126 (01) :74.e11-74.e17
[9]   Depression and Outcomes of Methadone and Buprenorphine Treatment among People with Opioid Use Disorders: A Literature Review [J].
Ghabrash, Maykel Farag ;
Bahremand, Arash ;
Veilleux, Martine ;
Blais-Normandin, Genevieve ;
Chicoine, Gabrielle ;
Sutra-Cole, Catherine ;
Kaur, Navdeep ;
Ziegler, Daniela ;
Dubreucq, Simon ;
Juteau, Louis-Christophe ;
Lestage, Laurent ;
Jutras-Aswad, Didier .
JOURNAL OF DUAL DIAGNOSIS, 2020, 16 (02) :191-207
[10]   Why aren't physicians prescribing more buprenorphine? [J].
Huhn, Andrew S. ;
Dunn, Kelly E. .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2017, 78 :1-7